Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Nektar Therapeutics (NKTR)

59 0.56 (0.96%)

09-21 16:00

Open:

58.98

Pre. Close:

58.44

High:

59.66

Low:

58.167

Volume:

2,128,795

Market Cap:

10176M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

59.738 - 59.979

59.979 - 60.209

Low:

57.571 - 57.838

57.838 - 58.093

Close:

58.573 - 58.991

58.991 - 59.389

Technical analysis  (as of: 2018-09-21 4:29:35 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 75.16     One year: 81.48

Support:

Support1: 55.59    Support2: 46.25

Resistance:

Resistance1: 64.35    Resistance2: 69.76

Pivot:

62.62

Moving Averages:

MA(5): 58.15     MA(20): 63.36

MA(100): 61.48     MA(250): 64.07

MACD:

MACD(12,26): -0.44     Signal(12,26,9): 0.72

%K %D:

%K(14,3): 17.31     %D(3): 13.01

RSI:

RSI(14): 43.76

52-Week:

High: 111.36  Low: 22.02  Change(%): 157.4

Average Vol(K):

3-Month: 203501  10-Days 189595

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
NKTR has closed above bottom band by 26.6%. Bollinger Bands are 4.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-09-11T10:46:13-04:00
An Early Look At Nektar And Bristol-Myers Squibb's First Combination Phase 3 Trial

2018-09-10T20:42:53-04:00
Healthcare And Biotechnology Dashboard - Update

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

172.47

Shares Float (M)

169.74

% Held by Insiders

% Held by Institutions

90.70

Shares Short (K)

15659

Shares Short Prior Month (K)

Stock Financials

EPS

4.960

EPS Est. Current Year

-0.980

EPS Est. Next Year

-1.100

EPS Est. Next Quarter

-0.350

Forward EPS

-1.260

Book Value (p.s.)

5.740

PEG Ratio

-2.40

Profit Margin

66.46

Operating Margin

69.35

Return on Assets (ttm)

64.5

Return on Equity (ttm)

96.9

Qtrly Rev. Growth

3044.7

Gross Profit (p.s.)

0.854

Sales Per Share

EBITDA (p.s.)

0.434

Qtrly Earnings Growth

Operating Cash Flow (M)

919.85

Levered Free Cash Flow (M)

602.48

Valuation

P/E

11.90

P/E Growth Ratio

0.01

P/BV

10.28

P/S

1198554752.00

P/CF

11.06

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.